Last reviewed · How we verify
diclofenac 0.1% ophthalmic susp.
diclofenac 0.1% ophthalmic susp. is a Small molecule drug developed by Nemocnice Kolín. It is currently in Phase 1 development. Also known as: diclofenac 0.1%.
At a glance
| Generic name | diclofenac 0.1% ophthalmic susp. |
|---|---|
| Also known as | diclofenac 0.1% |
| Sponsor | Nemocnice Kolín |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- diclofenac 0.1% ophthalmic susp. CI brief — competitive landscape report
- diclofenac 0.1% ophthalmic susp. updates RSS · CI watch RSS
- Nemocnice Kolín portfolio CI
Frequently asked questions about diclofenac 0.1% ophthalmic susp.
What is diclofenac 0.1% ophthalmic susp.?
diclofenac 0.1% ophthalmic susp. is a Small molecule drug developed by Nemocnice Kolín.
Who makes diclofenac 0.1% ophthalmic susp.?
diclofenac 0.1% ophthalmic susp. is developed by Nemocnice Kolín (see full Nemocnice Kolín pipeline at /company/nemocnice-kol-n).
Is diclofenac 0.1% ophthalmic susp. also known as anything else?
diclofenac 0.1% ophthalmic susp. is also known as diclofenac 0.1%.
What development phase is diclofenac 0.1% ophthalmic susp. in?
diclofenac 0.1% ophthalmic susp. is in Phase 1.
Related
- Manufacturer: Nemocnice Kolín — full pipeline
- Also known as: diclofenac 0.1%
- Compare: diclofenac 0.1% ophthalmic susp. vs similar drugs
- Pricing: diclofenac 0.1% ophthalmic susp. cost, discount & access